Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Asset Writedowns and Impairment (2017 - 2025)

Perspective Therapeutics' Asset Writedowns and Impairment history spans 5 years, with the latest figure at $10.0 million for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 17141.38% to $10.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.3 million, a 1627.85% increase, with the full-year FY2025 number at $10.0 million, changed N/A from a year prior.
  • Asset Writedowns and Impairment hit $10.0 million in Q4 2025 for Perspective Therapeutics, up from $58000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for CATX hit a ceiling of $10.0 million in Q4 2025 and a floor of -$58000.0 in Q3 2024.
  • Historically, Asset Writedowns and Impairment has averaged $2.1 million across 3 years, with a median of $298000.0 in 2023.
  • Biggest five-year swings in Asset Writedowns and Impairment: plummeted 119.46% in 2024 and later soared 17141.38% in 2025.
  • Tracing CATX's Asset Writedowns and Impairment over 3 years: stood at $298000.0 in 2023, then plummeted by 80.54% to $58000.0 in 2024, then soared by 17141.38% to $10.0 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for CATX at $10.0 million in Q4 2025, $58000.0 in Q4 2024, and -$58000.0 in Q3 2024.